Publications
323
Citations
10,368
Est. group size
~11
Recurring co-author estimate
Active years
38
Publishing since 1988
This researcher studies blood cancers, especially chronic lymphocytic leukemia and mantle cell lymphoma, focusing on how cancer cells interact with their surrounding tissue environment and immune cells, and how specific proteins and genetic signals drive tumor growth and survival. The work also explores new drug approaches, such as molecules that degrade specific cancer-promoting proteins and antibody-based therapies, aiming to translate laboratory findings into potential treatments. Publications span basic molecular biology, drug development, and early-phase clinical trial data related to blood cancers.
Publication output has fluctuated over the past decade with a notable peak in 2023, but appears to be declining in 2024-2025 based on available data.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PO-05-101 ROLE OF PROTEIN PHOSPHATASE 2A-B56Α IN REGULATION OF THE ARRHYTHMOGENIC LATE SODIUM CURRENT
Heart Rhythm · 2025
- Exploration of a green route for the synthesis of biological and environmentally applicative zinc oxide/silver/chitosan nanocomposite
Materials Research Innovations · 2025
- Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia
Nature Communications · 2024
- Abstract 3165: Targeting angiogenesis for improved survival in mantle cell lymphoma
Cancer Research · 2024
- Abstract 2997: Identification of novel long non-coding RNAs in mantle cell lymphoma patients
Cancer Research · 2024
- Molecular identification of contagious ecthyma in Kanni and Kodi goats breeds of Virudhunagar district, Tamil Nadu
International Journal of Advanced Biochemistry Research · 2024
- Abstract 4140343: Role of a novel protein phosphatase 2A activating drug in the regulation of late sodium current.
Circulation · 2024
- Tumor Microenvironment-Induced Interleukin-6 Regulates Proliferation and Survival in Patients with Mantle Cell Lymphoma (MCL) By Activating FGFR1 Signaling
Blood · 2024
- Transcriptomic Analysis in Mantle Cell Lymphoma Patients Identified MALAT1 Long-Non-Coding RNA to Regulate Cell Cycle Progression By Modulating EZH2/p57/Sox11 Axis
Blood · 2024
- Comparative efficacy of acaricides on tick infestation in dairy cattle
Agriculture Association of Textile Chemical and Critical Reviews · 2024
- Occurrence of contagious ecthyma with uncommon tongue lesions in an organized goat farm in Tamil Nadu
Indian Journal of Comparative Microbiology Immunology and Infectious Diseases · 2024
- Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation
European Journal of Medicinal Chemistry · 2023
- Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
Leukemia · 2023
- Examination of the Impact of Triazole Position within Linkers on Solubility and Lipophilicity of a CDK9 Degrader Series
ACS Medicinal Chemistry Letters · 2023
- A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment
Blood Advances · 2023
- Blood×34
- The Journal of Immunology×10
- Cancer Research×9
- Blood Advances×8
- Immunology×3
- Eileen Hu
Medicine · The Ohio State University
- Max Yano
Medicine · The Ohio State University
- John C. Byrd
Medicine · The Ohio State University
- John Byrd
Medicine · The Ohio State University
- Adam S. Kittai
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile